Inflammation response of epithelial mucosa to chemo-radiotherapy cytotoxic effects leads to
mucositis, a painful side effect of antineoplastic treatments. About 40% of the patients treated …

Oral mucositis (OM) is a common, highly symptomatic complication of cancer therapy that
affects patients' function, quality of life, and ability to tolerate treatment. In certain patients …

Purpose To systematically review the literature and update the evidence-based clinical
practice guidelines for the use of photobiomodulation (PBM), such as laser and other light …

Despite the enthusiasm surrounding novel targeted agents and immunotherapies,
chemotherapy remains the mainstay treatment for most human malignancies, either alone or …

The Canadian Cancer Society estimated that 220,400 new cases of cancer would be
diagnosed in 2019. Of the affected patients, more than 60% will survive for 5 years or longer …

Mucositis research and treatment are a rapidly evolving field providing constant new
avenues of research and potential therapies. The MASCC/ISOO Mucositis Study Group …

Cancer, a major world public health problem, is associated with chemotherapy treatments
whose administration leads to secondary concerns, such as oral mucositis (OM). The OM …

Oral mucositis (OM) is a major limiting acute side effect of radiotherapy for head and neck
cancer. The spectrum of problems associated with mucositis includes oral pain …

Purpose Diarrhea is one of the dose limiting toxicity of irinotecan. SN-38 is main irinotecan
metabolite responsible for diarrhea development, which is excreted in glucuronidated form …

Chemotherapy has allowed an increase in cancer survivorship, but it causes important
adverse effects. Mucositis affecting the gastrointestinal tract is one of the main problems …